Vertebral involvement in Erdheim-Chester disease: a case report of non-BRAF-driven diagnosis and treatment challenges

Erdheim–Chester disease (ECD) is a rare non-Langerhans cell histiocytosis that is frequently misdiagnosed because of its nonspecific systemic symptoms. We report the case of a 73-year-old woman who presented with persistent back pain, abdominal discomfort, and fever. Imaging revealed predominant thoracolumbar vertebral involvement, characterized by multifocal osteosclerosis on computed tomography and abnormal signal intensity with contrast enhancement on magnetic resonance imaging. This radiologic pattern may closely mimic inflammatory disorders, hematologic malignancies, or metastatic disease. Vertebral biopsy established the diagnosis of ECD. Molecular analysis of peripheral blood did not identify actionable driver mutations in the MAPK/PI3K signaling pathways, including BRAF V600E, highlighting the diagnostic and therapeutic challenges associated with non– BRAF -driven ECD. Despite corticosteroid therapy and supportive management, the disease followed an aggressive clinical course with a poor outcome. This case underscores vertebral and bone marrow–dominant ECD as an underrecognized presentation and emphasizes the importance of integrating histopathology, imaging findings, and molecular profiling to reduce diagnostic delay and inform management when targetable mutations are absent.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-04-28
DOI
https://doi.org/10.3389/fonc.2026.1785307
Primary Topic
Histiocytic Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Vertebral involvement in Erdheim-Chester disease: a case report of non-BRAF-driven diagnosis and treatment challenges

Lingzhi Wu, Shanshan Lin, Haocheng Zhao, Wenqiu Wu et al.
Frontiers in Oncology
Histiocytic Disorders and Treatments
article

Vertebral involvement in Erdheim-Chester disease: a case report of non-BRAF-driven diagnosis and treatment challenges

Lingzhi Wu, Shanshan Lin, Haocheng Zhao, Wenqiu Wu, Weifei Xie
article en

Abstract

Erdheim–Chester disease (ECD) is a rare non-Langerhans cell histiocytosis that is frequently misdiagnosed because of its nonspecific systemic symptoms. We report the case of a 73-year-old woman who presented with persistent back pain, abdominal discomfort, and fever. Imaging revealed predominant thoracolumbar vertebral involvement, characterized by multifocal osteosclerosis on computed tomography and abnormal signal intensity with contrast enhancement on magnetic resonance imaging. This radiologic pattern may closely mimic inflammatory disorders, hematologic malignancies, or metastatic disease. Vertebral biopsy established the diagnosis of ECD. Molecular analysis of peripheral blood did not identify actionable driver mutations in the MAPK/PI3K signaling pathways, including BRAF V600E, highlighting the diagnostic and therapeutic challenges associated with non– BRAF -driven ECD. Despite corticosteroid therapy and supportive management, the disease followed an aggressive clinical course with a poor outcome. This case underscores vertebral and bone marrow–dominant ECD as an underrecognized presentation and emphasizes the importance of integrating histopathology, imaging findings, and molecular profiling to reduce diagnostic delay and inform management when targetable mutations are absent.

Frontiers in OncologyVol. 16
Yueqing People's Hospital (CN)
No poverty
Openalex Percentile: Top 11%
Histiocytic Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.